Pharmazz India Private Limited, a active foreign private limited company, was established on 16 March 2011 in New Delhi, Delhi, India. Engaging in drug formulation & development within the professional, scientific and technical sector, it holds CIN: U24100DL2011FTC215954. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹4.81 Cr.
It upholds a compliant status. Employing 37 professional, Its leadership includes Anil Gulati (Director), Sunil Gulati (Director), Lov Verma (Director). Past directors included Ajit Chand Srimal, Sangita Gulati, Sunil Gulati. Its latest AGM occurred on 10 September 2024, with the balance sheet filed on 31 March 2024. It is based at Flat No.4, Pocket B, Sarita Vihar, New Delhi, Delhi, 110076.
U24100DL2011FTC215954
215954
16 March 2011
₹5.00 Cr
₹4.81 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Pharmazz India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anil Gulati | Director | 16 Mar 2011 | Current |
| Sunil Gulati | Director | 16 Mar 2011 | Current |
| Lov Verma | Director | 04 Feb 2017 | Current |
| Manish Subhashrao Lavhale | Managing Director | 14 Aug 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Chief Executive Officer | - | Past |
| Pramod Abcsdd | Director | 17 Oct 2019 | Past |
| Pramod Abcsdd | Whole-Time Director | 23 Nov 2022 | Past |
| Pramod Abcsdd | Director | 05 Oct 2021 | Past |
| Pramod Abcsdd | Additional Director | 28 Jul 2017 | Past |
| Pramod Abcsdd | Whole-Time Director | 23 Nov 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Pharmazz India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 50.8% increase. The company also saw a substantial improvement in profitability, with a 261.02% increase in profit. The company's net worth moved up by a moderate rise of 5.26%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Pharmazz India had a promoter holding of 79.78% and a public holding of 20.22%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Pharmazz India has a workforce of 37 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Pharmazz India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmazz India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Pharmazz India Private Limited last Annual general meeting of members was held on 10 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Pharmazz India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
The activity Manish Subhashrao Lavhale was appointed as a Managing Director was appointed as a Managing Director on 14 Aug 2021 & has been associated with this company since 4 years 3 months . was completed.
Lov Verma was appointed as a Director was appointed as a Director on 04 Feb 2017 & has been associated with this company since 8 years 9 months . was recorded as a recent event.
The activity Anil Gulati was appointed as a Director was appointed as a Director on 16 Mar 2011 & has been associated with this company since 14 years 8 months . was completed.
Sunil Gulati was appointed as a Director was appointed as a Director on 16 Mar 2011 & has been associated with this company since 14 years 8 months . was recorded as a recent event.
Pharmazz, Inc., today announced that it has received permission to initiate a prospective, multicentric, randomized, double-blind, parallel, phase III clinical study to assess efficacy of PMZ-1620 along with standard treatment in patients of acute ischemic stroke in India..
The CIN of Pharmazz India Private Limited is U24100DL2011FTC215954.
Pharmazz India Private Limited is headquartered at Flat No.4, Pocket B, Sarita Vihar, New Delhi, Delhi, 110076.
Pharmazz India Private Limited was incorporated on 16 March 2011.
The current directors of Pharmazz India Private Limited are
The primary industry of Pharmazz India Private Limited is Professional, Scientific And Technical.
Pharmazz India Private Limited is unlisted.
The authorized capital of Pharmazz India Private Limited is ₹5.00 Cr, and the paid-up capital is ₹4.81 Cr.
The compliance status of Pharmazz India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX